Webinar | July 21, 2020

Supply Chain Models For Global Trials: Singapore As The APAC Gateway To The World

Source: Catalent

With an increasing number of clinical studies being conducted in the Asia-Pacific (APAC) region, there is a growing need for streamlining import and export strategies and clinical supply support. Multiple factors, including positive changes in clinical research regulations, reduced costs to run trials, and large urban-centered populations are attracting sponsors to the region.

Singapore has long been a gateway into the region for sponsors, offering well-established regulations and an excellent infrastructure. The city can serve as an ideal hub for the import and export of clinical supplies into and throughout the APAC region.

Watch this webinar to get expert insight on using Singapore as a clinical supply hub.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: